[144] Silicon Laboratories Inc SEC Filing

Rhea-AI Filing Summary

Form 144 notice by an insider proposing sale of Silicon Laboratories Inc. common stock. The filer plans to sell 8,000 shares through Fidelity Brokerage Services with an aggregate market value of $1,161,818.01 on or about 08/22/2025. The shares were acquired via an option granted on 01/28/2016 and payment on sale is listed as cash. The issuer's outstanding shares are reported as 32,815,310. A recent sale by Brandon Tolany of 2,270 shares on 08/19/2025 generated $301,206.53. The filer certifies no undisclosed material adverse information.

Positive

• Public disclosure of proposed insider sale under Rule 144 increases transparency for investors
• Transaction details provided: number of shares, aggregate market value, acquisition date, and broker are listed

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider plans a small-block sale of 8,000 shares (~$1.16M) disclosed under Rule 144, consistent with routine liquidity transactions.

The filing documents a proposed sale executed through Fidelity for 8,000 common shares with an aggregate market value of $1,161,818.01, to occur on or about 08/22/2025. The shares trace to an option grant dated 01/28/2016 and will be paid in cash. The filing also reports a recent sale of 2,270 shares on 08/19/2025 by Brandon Tolany for $301,206.53. This notice provides transparency on insider disposition and conforms to Rule 144 disclosure mechanics; there is no financial performance data or forward-looking information in the filing.

Corporate Governance Expert

TL;DR: The Form 144 provides required public notice of insider selling and includes a representation of no undisclosed material information.

The filer certifies they are unaware of undisclosed material adverse information and references a potential Rule 10b5-1 trading plan condition in the remarks. The record shows the transaction source as an option granted by the issuer and that sales are being routed through an institutional broker. The filing is procedural and focuses on compliance with disclosure obligations rather than signaling corporate governance changes or material events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8000	1161818.01	32815310	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Option Granted - 01/28/2016	Issuer			8000	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brandon Tolany 400 West Cesar Chavez Austin TX 78701	Common	08/19/2025	2270	301206.53

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the SLAB Form 144?

The filer reports a proposed sale of 8,000 common shares of Silicon Laboratories (SLAB) with an aggregate market value of $1,161,818.01, to be executed around 08/22/2025 through Fidelity Brokerage Services.

How were the shares being sold acquired according to the filing?

The shares were acquired via an option granted on 01/28/2016, and the filing lists the amount to be sold as 8,000 shares.

Does the filing disclose any recent insider sales for SLAB?

Yes. The filing reports a sale on 08/19/2025 by Brandon Tolany of 2,270 shares, generating $301,206.53 in gross proceeds.

Through which broker will the SLAB shares be sold?

The proposed sale is to be executed through Fidelity Brokerage Services LLC, located at the address shown in the filing.

Does the filer assert any undisclosed material information in the Form 144?

The filer signs a representation that they do not know of any material adverse information about the issuer that has not been publicly disclosed.